canada semaglutide patent Your Questions Answered: Off-patent in 2026 Semaglutide patent expiry opens door

You can note your injection site for future rotation and mark your calendar for your next dose to ensure you dont miss it

How soon will I see the results

The immediate-release version is taken two to three times daily

Micronutrient and protein shortfalls Reduced appetite reduced intake reduced building blocks for hair

Tirzepatide may be particularly beneficial for: Individuals with obesity or those who are higher weight Patients seeking sustainable, long-term weight loss Those experiencing a weight loss plateau on semaglutide Individuals aiming to maintain their weight without rebound gain Many patients report increased satisfaction with their progress and more visible results